Literature DB >> 16533377

Nasointestinal intubation with tiger tubes: a case series indicates risk of mucosal damage.

S J Taylor1, A Pullyblank, A Manara.   

Abstract

Abstract In five intubations using the tiger tube (Cook) two were successfully placed into the small intestine. Two of the three intubation failures were due to early death due to the underlying condition. Nasointestinal placement permitted successful enteral feeding. Unfortunately, both nasointestinal placements were associated with mucosal damage that appears to be related to the tube "flaps". The tiger tube facilitates nasointestinal tube placement but until concerns regarding safety are addressed its clinical use cannot be recommended.

Entities:  

Mesh:

Year:  2006        PMID: 16533377     DOI: 10.1111/j.1365-277X.2006.00674.x

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  4 in total

1.  Health technology assessment in critical care.

Authors:  Damon C Scales; Andreas Laupacis
Journal:  Intensive Care Med       Date:  2007-10-20       Impact factor: 17.440

Review 2.  Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

Authors:  Adam Deane; Marianne J Chapman; Robert J Fraser; Laura K Bryant; Carly Burgstad; Nam Q Nguyen
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

3.  Comparison of a new unguided self-advancing jejunal tube with the endoscopic guided technique: a prospective, randomized study.

Authors:  Ulrike Holzinger; Reinhard Kitzberger; Andja Bojic; Marlene Wewalka; Wolfgang Miehsler; Thomas Staudinger; Christian Madl
Journal:  Intensive Care Med       Date:  2009-06-16       Impact factor: 17.440

4.  A new technique for bedside placement of enteral feeding tubes: a prospective cohort study.

Authors:  Günther Zick; Alexander Frerichs; Markus Ahrens; Bodo Schniewind; Gunnar Elke; Dirk Schädler; Inéz Frerichs; Markus Steinfath; Norbert Weiler
Journal:  Crit Care       Date:  2011-01-07       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.